Enter your email address:

Delivered by FeedBurner

China Gives Conditional Approval for Its First Self-Developed Alzheimer’s Drug

China Approves its First Alzheimer's Drug Oligomannate China has now
granted conditional approval to its first self-developed drug for
Alzheimer's disease, a move that may point to revived opportunities in
a therapeutic area where drugmakers have burned billions of dollars
without yielding a validated new drug. Oligomannate, which uses an
extract from marine brown algae […]

The post China Gives Conditional Approval for Its First Self-Developed
Alzheimer's Drug appeared first on BioTecNika .


Biotech News


Post a Comment